NCT00000281View on ClinicalTrials.gov

Pharmacotherapy for Schizophrenic Drug Users - 6

PHASE2CompletedINTERVENTIONAL
0
Timeline

Start Date

September 30, 1994

Primary Completion Date

August 31, 1999

Study Completion Date

August 31, 1999

Conditions
Cocaine-Related DisordersSubstance-Related DisordersShcizophrenia
Interventions
BEHAVIORAL

Amantadine

Trial Locations (1)

06519

VA Connecticut Healthcare System, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

VA Connecticut Healthcare System

FED

lead

Yale University

OTHER

NCT00000281 - Pharmacotherapy for Schizophrenic Drug Users - 6 | Biotech Hunter | Biotech Hunter